| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1998;66:1709-1714
© 1998 The Society of Thoracic Surgeons
a Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
b Genitourinary Oncology Service, Division of Solid Tumor Oncology, and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Address reprint requests to Dr Ginsberg, Division of Thoracic Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, C-881, New York, NY 10021
e-mail: (GinsbergR{at}mskcc.org)
Presented at the Thirty-fourth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 26–28, 1998.
Background. The role of surgery in patients with pulmonary metastatic germ cell tumors has been evolving since the 1970s. To evaluate the results of pulmonary resection, we reviewed our 28-year experience.
Methods. Between July 1967 and May 1995, 157 patients with testicular germ cell tumors underwent pulmonary resections for suspected metastases. Their clinical and pathological data were reviewed. Kaplan-Meier and Cox regression models were used to analyze prognostic factors for survival after resection of metastatic disease.
Results. All patients were male with median age of 27 years (range 15–65). Complete resection was accomplished in 155 (99%) patients. Viable carcinoma was present in 44% (70) of the patients. Forty-one (26%) patients had metastases to other sites after pulmonary metastasectomy. The overall actuarial survival 5 years after pulmonary resection was 68% for the entire group and 82% for patients diagnosed after 1985. On multivariate analysis, the adverse prognostic factors were metastases to nonpulmonary visceral sites (p = 0.0069) and the presence of viable carcinoma in the resected specimen (p < 0.0001).
Conclusions. With current chemotherapy regimens, almost 85% of the patients with testicular germ cell tumors undergoing complete resection of their pulmonary metastases can be expected to achieve long-term survival.
This article has been cited by other articles:
|
|
 |
|
  P. E. Van Schil, J. M. Hendriks, B. P. van Putte, B. A. Stockman, P. R. Lauwers, P. W. ten Broecke, M. J. Grootenboers, and F. M. Schramel Isolated lung perfusion and related techniques for the treatment of pulmonary metastases Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 487 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Poncelet, A. Lurquin, B. Weynand, Y. Humblet, P. Noirhomme, and on behalf of the 'Groupe d' Oncologie Thoracique D Prognostic factors for long-term survival in patients with thoracic metastatic disease: a 10-year experience Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 173 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Kesler, J. L. Wilson, J. A. Cosgrove, J. A. Brooks, A. Messiha, N. S. Fineberg, L. H. Einhorn, and J. W. Brown Surgical salvage therapy for malignant intrathoracic metastases from nonseminomatous germ cell cancer of testicular origin: Analysis of a single-institution experience J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 408 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Kesler, J. A. Brooks, K. M. Rieger, N. S. Fineberg, L. H. Einhorn, and J. W. Brown Mediastinal metastases from testicular nonseminomatous germ cell tumors: Patterns of dissemination and predictors of long-term survival with surgery J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 913 - 923. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
